Evaluation of Total Bile Acid and Aminotransferases in HIV/AIDS Patients with Coinfection of Hepatitis B and C Viruses

Patients confirmed to be seropositive for human immunodeficiency Virus (HIV) infection by Western blot technique attending Baptist Medical Centre, Saki, Oyo state-Nigeria were studied; including 30 males; 30 females; 20HIV mono-infected, 20HIV-HBV co-infected, 20HIV-HCV co-infected subjects aged 16 to 65 years. Age and sex matched apparently healthy HIV, HCV and HBV seronegative, subjects (N=50) consisting of 25 (50%) males and 25 (50%) females were recruited as controls. Plasma ALT, AST and Total Bile Acids were determined in the subjects biochemically by spectrophotometry. Antibody to hepatitis C virus and surface antigen to hepatitis B virus was determined in the subjects immunochemically by ELISA. The result obtained showed a significantly higher mean value of plasma ALT,AST and Total Bile Acids in HIV patients co-infected with hepatitis B or C virus than the values obtained in the control subjects(p<0.01). There was a significantly higher mean value of AST in the HIV mono-infected than the result obtained from the control subjects with p<0.01. There was a significantly higher mean plasma value of ALT in HIV patients co-infected with hepatitis B or C virus compared with the HIV mono-infected patients with p<0.01. None of the patients was found to have triple infection. Finally there was no significant difference in the degree of severity of hepatitis B or C or liver disorder in the immunosuppressed HIV patients co-infected with HBV compared with the HIV patients co-infected with HCV considering the alterations in the plasma level of the biochemical parameters.

[1]  S. Obi The Effect of Co-infection of HIV and Hepatotropic Viruses on Selected Biochemical and Haematological Markers of Patients in Northeastern Nigeria , 2014 .

[2]  B. Ibeh,et al.  Biochemical and haematological changes in HIV subjects receiving winniecure antiretroviral drug in Nigeria , 2013, Journal of Biomedical Science.

[3]  W. Worodria,et al.  Overt diabetes mellitus among newly diagnosed Ugandan tuberculosis patients: a cross sectional study , 2013, BMC Infectious Diseases.

[4]  J. Chilongola,et al.  The evolution of haematological and biochemical indices in HIV patients during a six-month treatment period. , 2012, African health sciences.

[5]  E. Ekong,et al.  A survey of hepatitis B and C virus prevalence in human immunodeficiency virus positive patients in a tertiary health institution in North Eastern Nigeria , 2012 .

[6]  E. Ugwu,et al.  Coinfection with hepatitis B and C viruses among HIV positive pregnant women in Enugu south east, Nigeria. , 2012, Nigerian Journal of Medicine.

[7]  E. Anteyi,et al.  Hepatitis B and C virus co-infection in Nigerian patients with HIV infection. , 2009, Journal of infection in developing countries.

[8]  I. Adewole,et al.  Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients. , 2008, Annals of hepatology.

[9]  D. Egah,et al.  Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria. , 2007, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[10]  M. Sulkowski Drug-induced liver injury associated with antiretroviral therapy that includes HIV-1 protease inhibitors. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  R. Chung,et al.  Alanine Aminotransferase Levels Predict Insulin Resistance in HIV Lipodystrophy , 2003, Journal of acquired immune deficiency syndromes.

[12]  D. Vlahov,et al.  The natural history of hepatitis C virus infection: host, viral, and environmental factors. , 2000, JAMA.

[13]  M. Kaplan,et al.  Evaluation of abnormal liver-enzyme results in asymptomatic patients. , 2000, The New England journal of medicine.

[14]  J. Gill,et al.  Immunobiology of hepatitis C virus (HCV) infection: the role of CD4 T cells in HCV infection , 2000, Immunological reviews.

[15]  K. Byth,et al.  Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease , 1996, Journal of gastroenterology and hepatology.